Joseph P. Hagan, President and CEO at Regulus Therapeutics Inc. (RGLS), bought 100,000 shares at $0.22 ($22K) on 2022-01-26, disclosed to the SEC on 2022-01-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| RGLS | SELL | 2024-01-18 | $17K | — | Filing → |
| AUPH | SELL | 2023-05-23 | $3K | — | Filing → |
| AUPH | SELL | 2022-01-04 | $1.8M | — | Filing → |